Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis
Status:
Completed
Trial end date:
2015-01-07
Target enrollment:
Participant gender:
Summary
This study will compare the effectiveness of denosumab treatment every 6 months with once
yearly zoledronic acid treatment on bone mineral density (BMD) at various skeletal sites.